Joseph S. Zakrzewski - 12 May 2022 Form 4 Insider Report for Cyteir Therapeutics, Inc.

Role
Director
Signature
/s/ Adam M. Veness, as attorney-in-fact for Joseph Zakrzewski
Issuer symbol
N/A
Transactions as of
12 May 2022
Net transactions value
+$1,196
Form type
4
Filing time
16 May 2022, 16:24:11 UTC
Previous filing
12 May 2022
Next filing
08 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYT Common Stock Purchase $1,196 +743 +0.56% $1.61 133,416 12 May 2022 Direct F1
holding CYT Common Stock 58,671 12 May 2022 See Footnote F2
holding CYT Common Stock 149,051 12 May 2022 See Footnote F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 55,102 of the shares of common stock held directly and indirectly by the Reporting Person were acquired upon early exercise of an option and are subject to forfeiture until they vest.
F2 Shares held by Z Investments, LLC, of which the Reporting Person is the Managing Director. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
F3 Shares held by Z3 Trust, of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.